Algorithms for optoacoustically controlled selective retina therapy (SRT).

Algorithm Feedback Lasers in medicine Ophthalmology Optoacoustics RPE Retina therapy SRT Selectivity

Journal

Photoacoustics
ISSN: 2213-5979
Titre abrégé: Photoacoustics
Pays: Germany
ID NLM: 101622604

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 06 08 2021
revised: 19 10 2021
accepted: 09 11 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

Selective Retina Therapy (SRT) uses microbubble formation (MBF) to target retinal pigment epithelium (RPE) cells selectively while sparing the neural retina and the choroid. Intra- and inter-individual variations of RPE pigmentation makes frequent radiant exposure adaption necessary. Since selective RPE cell disintegration is ophthalmoscopically non-visible, MBF detection techniques are useful to control adequate radiant exposures. It was the purpose of this study to evaluate optoacoustically based MBF detection algorithms. Fifteen patients suffering from central serous chorioretinopathy and diabetic macula edema were treated with a SRT laser using a wavelength of 527 nm, a pulse duration of 1.7 µs and a pulse energy ramp (15 pulses, 100 Hz repetition rate). An ultrasonic transducer for MBF detection was embedded in a contact lens. RPE damage was verified with fluorescence angiography. An algorithm to detect MBF as an indicator for RPE cell damage was evaluated. Overall, 4646 irradiations were used for algorithm optimization and testing. The tested algorithms were superior to a baseline model. A sensitivity/specificity pair of 0.96/1 was achieved. The few false algorithmic decisions were caused by unevaluable signals. The algorithm can be used for guidance or automatization of microbubble related treatments like SRT or selective laser trabeculoplasty (SLT).

Identifiants

pubmed: 34926158
doi: 10.1016/j.pacs.2021.100316
pii: S2213-5979(21)00075-6
pmc: PMC8649889
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100316

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ralf Brinkmann is inventor of patents, which are hold by the Medizinisches Laserzentrum Lübeck GmbH and licensed to commercial entities that are related to the technology and analysis methods described in this study. Data were acquired and processed by coauthors unaffiliated with any commercial entity.

Références

Health Phys. 1985 Jun;48(6):781-96
pubmed: 3997529
Ann Allergy Asthma Immunol. 1998 Nov;81(5):428-30
pubmed: 9860035
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
Exp Eye Res. 1978 Oct;27(4):471-93
pubmed: 103737
Ophthalmic Surg Lasers. 2002 Sep-Oct;33(5):400-9
pubmed: 12358294
Arch Ophthalmol. 1984 Jun;102(6):825
pubmed: 6732561
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6654-62
pubmed: 26567781
Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1263-72
pubmed: 20393742
Br J Ophthalmol. 2011 Jan;95(1):83-8
pubmed: 20554506
J Biomed Opt. 2007 Nov-Dec;12(6):064034
pubmed: 18163850
J Biomed Opt. 2005 Nov-Dec;10(6):064014
pubmed: 16409079
Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1703-13
pubmed: 26803489
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8643-7
pubmed: 8378341
Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1639-1651
pubmed: 30056549
Ophthalmologica. 2015;234(4):177-88
pubmed: 26368551
Medicine (Baltimore). 2016 Jan;95(3):e2524
pubmed: 26817895
Clin Exp Ophthalmol. 2014 Dec;42(9):846-55
pubmed: 24698550
J Biomed Opt. 2004 Jan-Feb;9(1):173-9
pubmed: 14715070
J Biomed Opt. 2005 Nov-Dec;10(6):064022
pubmed: 16409087
Int J Comput Assist Radiol Surg. 2016 Jun;11(6):863-71
pubmed: 27067098
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):243-254
pubmed: 27497611
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):714-9
pubmed: 15671304
Biomed Opt Express. 2018 Jun 26;9(7):3320-3334
pubmed: 29984100
Lasers Surg Med. 2000;27(5):451-64
pubmed: 11126439
Arch Ophthalmol. 1992 Dec;110(12):1786-92
pubmed: 1463423
Curr Eye Res. 2009 Jul;34(7):568-79
pubmed: 19899970
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1375-1383
pubmed: 28421342
J Biomed Opt. 2018 Nov;23(11):1-12
pubmed: 30392199
Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):32
pubmed: 33755044

Auteurs

Eric Seifert (E)

Medizinisches Laserzentrum Lübeck GmbH, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.

Jan Tode (J)

Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Amelie Pielen (A)

Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Dirk Theisen-Kunde (D)

Medizinisches Laserzentrum Lübeck GmbH, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.

Carsten Framme (C)

Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

Johann Roider (J)

Klinik für Ophthalmologie, Universitätsklinikum Schleswig-Holstein, Arnold-Heller-Straße, 24105 Kiel, Germany.

Yoko Miura (Y)

Medizinisches Laserzentrum Lübeck GmbH, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.
Institut für Biomedizinische Optik, Universität zu Lübeck, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.

Reginald Birngruber (R)

Institut für Biomedizinische Optik, Universität zu Lübeck, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.

Ralf Brinkmann (R)

Medizinisches Laserzentrum Lübeck GmbH, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.
Institut für Biomedizinische Optik, Universität zu Lübeck, Peter-Monnik-Weg 4, 23562 Lübeck, Germany.

Classifications MeSH